MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12916-016-0701-8

Медицинская библиотека · BMC medicine · 2016

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.

Leang Rithea, Khu Naw Htee, Mukaka Mavuto, Debackere Mark, Tripura Rupam, Kheang Soy Ty, Chy Say, Kak Neeraj, Buchy Philippe, Tarantola Arnaud, Menard Didier, Roca-Felterer Arantxa, Fairhurst Rick M, Kheng Sim, Muth Sinoun, Ngak Song, Dondorp Arjen M, White Nicholas J, Taylor Walter Robert John

СтатьяПеревод в очереди

Аннотация

BACKGROUND

In 2012, the World Health Organization recommended the addition of single low-dose primaquine (SLDPQ, 0.25 mg base/kg body weight) to artemisinin combination therapies to block the transmission of Plasmodium falciparum without testing for glucose-6-phosphate dehydrogenase deficiency. The targeted group was non-pregnant patients aged ≥ 1 year (later changed to ≥ 6 months) with acute uncomplicated falciparum malaria, primarily in countries with artemisinin-resistant P. falciparum (ARPf). No dosing regimen was suggested, leaving malaria control programmes and clinicians in limbo. Therefore, we designed a user-friendly, age-based SLDPQ regimen for Cambodia, the country most affected by ARPf.

METHODS

By reviewing primaquine's pharmacology, we defined a therapeutic dose range of 0.15-0.38 mg base/kg (9-22.5 mg in a 60-kg adult) for a therapeutic index of 2.5. Primaquine doses (1-20 mg) were tested using a modelled, anthropometric database of 28,138 Cambodian individuals (22,772 healthy, 4119 with malaria and 1247 with other infections); age distributions were: 0.5-4 years (20.0 %, n = 5640), 5-12 years (9.1 %, n = 2559), 13-17 years (9.1 %, n = 2550), and ≥ 18 years (61.8 %, n = 17,389). Optimal age-dosing groups were selected according to calculated mg base/kg doses and proportions of individuals receiving a therapeutic dose.

RESULTS

Four age-dosing bands were defined: (1) 0.5-4 years, (2) 5-9 years, (3) 10-14 years, and (4) ≥15 years to receive 2.5, 5, 7.5, and 15 mg of primaquine base, resulting in therapeutic doses in 97.4 % (5494/5640), 90.5 % (1511/1669), 97.7 % (1473/1508), and 95.7 % (18,489/19,321) of individuals, respectively. Corresponding median (1st-99th centiles) mg base/kg doses of primaquine were (1) 0.23 (0.15-0.38), (2) 0.29 (0.18-0.45), (3) 0.27 (0.15-0.39), and (4) 0.29 (0.20-0.42).

CONCLUSIONS

This age-based SLDPQ regimen could contribute substantially to malaria elimination and requires urgent evaluation in Cambodia and other countries with similar anthropometric characteristics. It guides primaquine manufacturers on suitable tablet strengths and doses for paediatric-friendly formulations. Development of similar age-based dosing recommendations for Africa is needed.

Для цитирования: Leang Rithea, Khu Naw Htee, Mukaka Mavuto, Debackere Mark, Tripura Rupam, Kheang Soy Ty, Chy Say, Kak Neeraj, Buchy Philippe, Tarantola Arnaud, Menard Didier, Roca-Felterer Arantxa, Fairhurst Rick M, Kheng Sim, Muth Sinoun, Ngak Song, Dondorp Arjen M, White Nicholas J, Taylor Walter Robert John. An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia.. BMC medicine. 2016. DOI: 10.1186/s12916-016-0701-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.